Across TCGA pan-cancer cohorts, RPL15P13 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of RPL15P13’s most consistent transcriptional readouts.
The strongest signal is observed in stomach adenocarcinoma (STAD), where RPL15P13 RNA is repressed in tumor relative to normal tissue. In most cancer types RPL15P13 is over-expressed in tumor, although a few such as STAD and HNSC show the opposite, repressed pattern.
STAD, LIHC, and KIRC are the cancer types where RPL15P13 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL15P13 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.